本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Accendra Health Inc

1.07
-0.0140-1.30%
成交量:5.40萬
成交額:5.69萬
市值:8,198.04萬
市盈率:-0.27
高:1.08
開:1.06
低:1.05
收:1.08
52周最高:5.69
52周最低:0.9337
股本:7,690.47萬
流通股本:5,650.89萬
量比:1.73
換手率:0.10%
股息:- -
股息率:- -
每股收益(TTM):-3.9457
每股收益(LYR):-14.3179
淨資產收益率:-198.35%
總資產收益率:0.64%
市淨率:-0.15
市盈率(LYR):-0.07

資料載入中...

2025/12/08

重要事件披露

Form 8-K - Current report
2025/12/02

重要事件披露

Form 8-K - Current report
2025/10/31

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/30

重要事件披露

Form 8-K - Current report
2025/10/07

重要事件披露

Form 8-K - Current report
2025/09/19

重要事件披露

Form 8-K - Current report
2025/08/11

重要事件披露

Form 8-K - Current report
2025/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/06/06

重要事件披露

Form 8-K - Current report
2025/06/05

重要事件披露

Form 8-K - Current report
2023/04/25

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/08/31

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/08/22

自願退市

25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
2022/08/10

SEC問詢函

CORRESP [Cover] - Correspondence
2022/07/19

SEC問詢函

CORRESP [Cover] - Correspondence
2022/04/22

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/04/27

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/04/22

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/04/01

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals